Controlling blood uric acid after pancreatic cancer surgery to improve survival
Official title: Whether Controlling Serum Uric Acid (SUA) Can Benefit Postoperative Survival in Patients With Pancreatic Cancer
Run by Hepatopancreatobiliary Surgery Institute of Gansu Province · NCT07091526 · Data updated 2026-11-12
This analysis will see if changes in blood uric acid after pancreatic cancer surgery relate to survival for people who had their tumor removed.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 168 (estimated) |
| Sponsor | Hepatopancreatobiliary Surgery Institute of Gansu Province Academic / other |
| Locations | 1 site (Lanzhou, Gansu) |
| Status | Recruiting |
| Started | July 29, 2025 |
| Main results expected | December 29, 2026 |
| Study ends | December 29, 2026 |
| Registry record updated | December 19, 2025 |
| Trial ID | NCT07091526 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with pathologically confirmed primary pancreatic cancer who underwent radical resection (pancreaticoduodenectomy or distal pancreatectomy), have available pre- and postoperative uric acid measurements, and survived at least six weeks after surgery are the intended population.
✕Probably not a fit
Patients with preexisting gout, chronic kidney disease, use of long-term urate-lowering drugs, recent dialysis or plasma exchange, certain metabolic or hematologic disorders, nonpancreatic primary tumors, pregnant or postpartum women, or those lacking follow-up data are unlikely to benefit from these findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a retrospective observational analysis of patients with pathologically confirmed primary pancreatic cancer who underwent radical resection (pancreaticoduodenectomy or distal pancreatectomy) at a single center in Lanzhou, Gansu. Investigators will extract preoperative and postoperative serum uric acid (SUA) measurements from medical records and correlate changes in SUA with overall survival and postoperative outcomes, using available clinical data to adjust for confounders. Patients with conditions or treatments that substantially affect uric acid (for example gout, chronic kidney disease, or long-term urate-lowering therapy) are excluded to reduce bias. The study aims to determine whether perioperative changes in SUA can serve as a prognostic marker after pancreatic cancer resection.
Why it matters
Potential benefit: If successful, tracking postoperative uric acid changes could help identify patients at higher risk of poor survival and guide closer follow-up or targeted interventions.
How similar studies have gone: Some observational work has linked higher serum uric acid to worse outcomes in hepatobiliary cancers, but using postoperative change in SUA as a prognostic marker specifically for pancreatic cancer is novel and not yet established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with pathologically confirmed pancreatic cancer (primary) * Patients who underwent Radical resection of pancreatic cancer(Pancreaticoduodenectomy or Distal pancreatectomy) * The postoperative survival time was at least 6 weeks Exclusion Criteria: * No surgery was performed, or only palliative surgery/ biopsy was performed * Patients who underwent emergency hemodialysis or plasma exchange after surgery * History of gout or long-term urate-lowering therapy, such as allopurinol * Patients are missing follow-up data * Hydrochlorothiazide and furosemide were used * Chronic kidney disease * Oncolytic syndrome * Hemolytic anemia * Lead poisoning * Hyperparathyroidism * Hypothyroidism * A tyrosinase inhibitor was used * Patients with nonpancreatic primary tumors * Pregnant or postpartum women.
Where it's running
-
Hepatopancreatobiliary Surgery Institute of Gansu Province
Lanzhou, Gansu, China Recruiting
Study contacts
- Principal investigator: Wenbo Meng, M.D. Ph. D. — Hepatopancreatobiliary Surgery Institute of Gansu Province
- Study coordinator: Wenbo Meng, M.D. Ph. D.
- Email: mengwb@163.com
- Phone: 13919177177
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of suctioning on pain and stress in intubated ICU patients
This study is testing if suctioning the breathing tube in ICU patients causes more pain and stress compared to not suctioning.
-
Lowering or stopping febuxostat in people with gout who have been well controlled for 5+ years
This test will see if reducing or briefly stopping febuxostat keeps uric acid low and prevents symptom return in people with gout who have had good control for at least five years.
-
Evaluating allopurinol's effect on cardiovascular events in high-risk patients
This study is testing if the medication allopurinol can help reduce heart problems in people aged 40-70 who have high uric acid levels and are at risk for cardiovascular issues.
-
Using sodium bicarbonate to change 24-hour urine measurements in people with low urine citrate or uric acid kidney stones
This will see if taking sodium bicarbonate instead of potassium citrate changes 24-hour urine measurements in adults with low urine citrate or uric acid kidney stones.
-
Understanding pediatric hypertension and its effects on the body
This study looks at how different factors related to blood pressure affect children aged 7-18 who have just been diagnosed with high blood pressure, to see how it impacts their health over two years.
-
Effects of bile acids on glucose metabolism after gastric bypass surgery
This study is testing how bile acids affect blood sugar levels in people who have had gastric bypass surgery by giving some participants a medication and comparing their results to others.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.